About Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to – more... 

Reviews

Overall

4.0
Based on 4 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
4.0
Compensation/Benefits
3.7
Job Security/Advancement
3.0
Management
4.7
Culture
4.3
Claim this company page
Headquarters
Irvine California, United States
Revenue
$153.6 Million
Employees
501 to 1,000
Links
Endologix website